NOAEL Studies
Cosmetic Ingredient
2,6-Dihydroxy-3,4-Dimethylpyridine NOAEL Studies
INCI: 2,6-DIHYDROXY-3,4-DIMETHYLPYRIDINE
CAS: 84540-47-6
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 160 | mg/kg bw/day | rat | oral | 6-20 Gestation day | Developmental | SCCP; Marburger, A. and Flade, D. (2005). Prenatal developmental toxicity study in the Han Wistar rat. RCC Ltd, Itingen, Switzerland, internal study code 854665. Archive code at Henkel KGaA, Düsseldorf, Report No. R 0500122 |
| COSMOS DB | NOAEL | 80 | mg/kg bw/day | rat | oral | 6-20 Gestation day | Developmental | SCCP; Marburger, A. and Flade, D. (2005). Prenatal developmental toxicity study in the Han Wistar rat. RCC Ltd, Itingen, Switzerland, internal study code 854665. Archive code at Henkel KGaA, Düsseldorf, Report No. R 0500122 |
SCCS Opinion 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.017 | mg/kg | rat | oral | - | dermal absorption | p.21 |
| SCCS Opinion | NOAEL | =80 | mg/kg | human | oral | - | developmental toxicity | p.20 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw | rat | - | Chronic | genotoxicity | p.15 |
| SCCS Opinion | NOAEL | =100 | mg/kg | rabbit | oral | 90 days | dermal absorption | p.21 |
| SCCS Opinion | NOAEL | =1000 | mg/kg | - | oral | Sub-chronic | repeated dose toxicity | p.14 |
Regulatory source 7 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | dermal absorption | =0.017 | mg/kg | rat | oral | - | dermal absorption | p.21 |
| Regulatory source | dermal absorption | =80 | mg/kg | rat | oral | - | dermal absorption | p.21 |
| Regulatory source | dermal absorption | 80 | mg/kg | rabbit | oral | 90 days | dermal absorption | p.21 |
| Regulatory source | dermal absorption | 100 | mg/kg | rabbit | oral | 90 days | dermal absorption | p.21 |
| Regulatory source | developmental toxicity | 80 | mg/kg | human | oral | - | developmental toxicity | p.20 |
| Regulatory source | genotoxicity | 100 | mg/kg bw | rat | - | Chronic | genotoxicity | p.15 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg | - | oral | Sub-chronic | repeated dose toxicity | p.14 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 3VDO3A5MTW | UNII | - | - | - | chemical | - |